Thrombotic thrombocytopenic purpura: Understanding a disease no longer rare

American Journal of the Medical Sciences

Volumn 316, Issue 2, 1998, Pages 105-119

  Moake, Joel L ^a,b   Chow, Thomas W ^a  

^a RICE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Thrombotic thrombocytopenic purpura; Unusually large von Willebrand factor; von Willebrand factor; vWf metalloproteinase

Indexed keywords

METALLOPROTEINASE; VON WILLEBRAND FACTOR;

CATALYSIS; CONFERENCE PAPER; CRYOPRECIPITATE; DISULFIDE BOND; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INHIBITION; ERYTHROCYTE FRAGILITY; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; SHEAR STRESS; SUPERNATANT; THROMBOCYTE AGGREGATION; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0031873311     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199808000-00006     Document Type: Conference Paper

References (123)

1. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc N Y Pathol Soc. 1924;24:21-4.
2. Rock GA, Sumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RS, Spasoff RA. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325:393-
3. Bell WR, Braine HG, Ness PM, Kickler TS. Improved survival in thrombotic thrombocytopenic purpura-hemolytic-uremic syndrome: clinical experience in 108 patients. N Engl J Med. 1991;325:398-402.
4. Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med. 1977;297:1386-9.
5. Bukowski RM, Hewlett JS, Reimer RR, Groppe CW, Weick JK, Livingston RB. Therapy of thrombotic thrombocytopenic purpura: an overview. Semin Thromb Hemost. 1981;7:1-8.
6. Shumak KH, Rock GA, Nair R, Members of the California Alpharesis Group. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Ann Intern Med. 1995;122:569-72.
7. Baehr G, Klemperer P, Schifrin A. An acute febrile anemia with thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles. Trans Assoc Am Physicians. 1936;65:43-58.
8. Harkness DR, Byrnes JJ, Lian EC-Y, Williams WD, Hensley GT. Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA. 1981;246:1931-3.
9. Neame PD. Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost. 1980;6:416-29.
10. Dekker A, O'Brien ME, Cammarata RJ. The association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus. Am J Med Sci. 1974;267:243-9.
11. Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG. Thrombotic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum. 1994; 24:172-5.
12. Case records of Massachusetts General Hospital. N Engl J Med. 1963;269:1195-1206.
13. Morey DA, White JB, Daily WM. Thrombotic thrombocytopenic purpura diagnosed by random lymph node biopsy. Arch Intern Med. 1956;98:821-3.
14. Steinberg AD, Green WT, Talal N. Thrombotic thrombocytopenic purpura complicating Sjogren's syndrome. JAMA. 1971;215:757-61.
15. Benitez L, Mathews M, Mallory GK. Platelet thrombosis with polyarteritis nodosa: report of a case. Arch Pathol. 1964;77:116-25.
16. McLeod BC, Wu KK, Knospe WH. Plasmapheresis in thrombotic thrombocytopenic purpura. Arch Intern Med. 1980;140:1059-60.
17. Myers TJ, Wakem CJ, Ball ED, Tremont SJ. Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents. Ann Intern Med. 1980;92:149-55.
18. Zacharski LR, Lustad D, Click JL. Thrombotic thrombocytopenic purpura in a previously splenectomized patient. Am J Med. 1976;60:1061-3.
19. Yospur LS, Sun NC, Figueroa P, Niihara Y. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: case reports and review of the literature. Am J Hematol. 1996;51:73-8.
20. Leaf AN, Laubenstein LJ, Raphael B, Hochster H, Baez L, Karpatkin S. Thrombotic thrombocytopenic purpura associated with immunodeficiency virus type I (HIV-1) infection. Ann Intern Med. 1988;109:194-7.
21. Nair JM, Bellevue R, Bertoni M, Dosik H. Thrombotic thrombocytopenic purpura in patients with the acquired immunodeficiency syndrome (AIDS)-related complex: a report of two cases. Ann Intern Med. 1988;109:209-12.
22. Tarantolo SR, Landmark JD, Iwen PC. Bartonella-like erythrocyte inclusions in thrombotic thrombocytopenic purpura. Lancet. 1997;350:1602.
23. Amorosi El, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1988;45:139-59.
24. Byrnes JJ, Moake JL. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome: evolving concepts of pathogenesis and therapy. Clinics Haematol. 1986; 15:413-42.
25. Chintagumpala M, Hurwitz R, Moake J, Mahoney D, Steuber C. Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission. J Pediatr. 1992;120:49-53.
26. Moake J, Chintagumpala M, Turner N, McPherson P, Nolasco L, Steuber C, et al. Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood. 1994;84:490-7.
27. Daghistani D, Jimenez JJ, Moake JL, Ledford MR, Yunis A. Thrombotic thrombocytopenic purpura. Pediatr Hematol Oncol. 1996;18:171-4.
28. Karpman D, Holmberg L, Jigard L, Lethagen S. Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura. Kidney Int. 1996;49:190-9.
29. del Arco A, Martinez MA, Pena JM, Gamallo C, Gonzalez JJ, Barbado FJ, Vasquez JJ. Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells. Clin Infect Dis. 1993;17:360-3.
30. Wada H, Minami N, Shirakawa S. Cytokine levels in patients with thrombotic thrombocytopenic purpura. Nippon Rinsho-Japanese J Clin Med. 1993;51:151-4.
31. Tandon NN, Rock G, Jamieson GA. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura. Br J Haematol. 1994;88:816-25.
32. Koenig DW, Barley-Maloney L, Daniel TO. A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies. J Clin Immunol. 1993;13:204-11.
33. Umibe T, Nawata Y, Mori N, Kanai H, Takabayashi K, Iwamoto I, et al. Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome. Ryumachi. 1994;34:981-7.
34. Laurence J, Mitra D, Steiner M, Staiao-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood. 1996;87:3245-54.
35. Nagaya S, Wada H, Oka K, Tanigawa M, Tamaki S, Tsuzi K, et al. Hemostatic abnormalities and increased vascular cell markers in patients with red cell fragmentation syndrome induced by mitomycin C. Am J Hematol. 1995;50:237-43.
36. Kobayashi M, Wada H, Wakita Y, Shimura M, Nakase T, Hiyoyama K, et al. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost. 1995;71:10-14.
37. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood. 1994;83:1535-41.
38. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol. 1994;87:343-7.
39. Katayama M, Handa M, Araki Y, Ambo H, Kawai Y, Wantanabe K, Ikeda Y. Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome. Br J Haematol. 1993; 84:702-10.
40. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Hayashi T, Tamaki S, et al. Increased levels of vascular endothelial cell markers in thrombotic thrombocytopenic purpura. Am J Hematol. 1993;44:101-5.
41. Hirosawa S, Koyama T. Thrombomodulin as a clinical marker in thrombotic thrombocytopenic purpura. Nippon Rinsho-Japanese J Clin Med. 1993;51:129-34.
42. Wada H, Ohiwa M, Kaneko T, Tamaki S, Tanigawa M, Shirakawa S, et al. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol. 1992;39:20-4.
43. Handa M, Katayama M, Ikeda Y. Detection of soluble forms of platelet membrane glycoproteins and its clinical significance. Nippon Rinsho-Japanese J Clin Med. 1992; 50:360-5.
44. Zauli G, Gugliotta L, Catani L, Vianelli N, Borgatti P, Belmonte MM, Tura S. Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis. Br J Haematol. 1993;84:381-6.
45. Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, et al. Plasma cytokine levels in thrombotic thrombocytopenic purpura. Am J Hematol. 1992;40:167-70.
46. Joseph G, Smith KJ, Hadley TJ, Djulbegovic B, Troup GM, Oldfather J, Barker RL. HLA-DR53 protects against thrombotic thrombocytopenic purpura/adult hemolytic uremic syndrome. Am J Hematol. 1994;47:189-93.
47. Neame PB, Lechago J, Ling ET, Koval A. Thrombotic thrombocytopenic purpura: report of a case with disseminated intravascular platelet aggregation. Blood. 1973; 42:805-14.
48. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K. Immunohistochemistry of vascular lesions in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res. 1985;38:469-79.
49. Asada Y, Sumiyoshi A. Histopathology of thrombotic thrombocytopenic purpura. Nippon Rinsho-Japanese J Clin Med. 1993;51:159-62.
50. Asada Y, Sumiyoshi A. Pathological features of thrombotic thrombocytopenic purpura. In: Kaplan B, Trompeter R, Moake J, eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:491-8.
51. Goodman A, Ramos R, Petrelli M, Hirsch SA, Bukowski R, Harris J. Gingival biopsy in thrombotic thrombocytopenic purpura. Ann Intern Med. 1978;89:501-4.
52. Chen S, Lian EC-Y. Purification and some properties of a 59 KDa platelet-aggregating protein from the plasma of a patient with thrombotic thrombocytopenic purpura (abstract). Blood. 1988;72:318.
53. Siddiqui FA, Lian EC-Y. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma. J Clin Invest. 1985;76:1330-7.
54. Siddiqui FA, Lian EC-Y. Characterization of platelet agglutinating protein p37 purified from the plasma of a patient with thrombotic thrombocytopenic purpura. Biochem Mol Biol Int. 1993;30:385-95.
55. Siddiqui FA, Lian EC-Y. Platelet-agglutinating protein p37 from thrombotic thrombocytopenic purpura plasma forms a complex with platelet membrane glycoprotein IV (CD36). Biochem Int. 1992;27:485-96.
56. Lian EC-Y, Siddiqui FA, Chen S-H, Feng L-M. Platelet agglutinating/aggregating proteins from the plasma of patients with thrombotic thrombocytopenic purpura. In: Kaplan B, Trompeter R, Moake J. eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:473-81.
57. Wu KK. Role of prostacyclin in the pathogenesis and therapy of thrombotic thrombocytopenic purpura. In: Kaplan B, Trompeter R, Moake J, eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:483-9.
58. Bobbio-Pallavicini E, Porta C, Tacconi F, Gugliotta L, Centurioni R, Vianelli N, et al. Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura: four case reports and review of the literature. Haematologica. 1994;79:429-37.
59. Kurosawa S, Nagata M, Saito T, Arai T, Momose T, Morio K, Mitsuhashi H. Thrombotic thrombocytopenic purpura (TTP) with a low level of apolipoprotein A-1 (Apo A-1) which responded to combination of vincristine and beraprost. Rinsho Ketueki-Japanese J Hematol. 1994;35:704-9.
60. Moore JC, Murphy WG, Kelton JG. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenia purpura. Br J Haematol. 1990;74:457-64.
61. Kelton JG, Warkentin TE, Hayward CP, Murphy WG, Moore JC. Calpain activity in patients with thrombotic thrombocytopenia purpura is associated with platelet microparticles. Blood. 1992;80:2246-51.
62. Kelton JG, Moore JC, Warkentin TE, Hayward CP. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura. Br J Haematol. 1996;93:421-6.
63. Consonni R, Falanga A, Barbui T. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenia purpura. Br J Haematol. 1994;87:321-4.
64. Sanders WE, Read M, Reddick RL, Garris JB, Brinkhous KM. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin: an animal model. Lab Invest. 1988;59:443.
65. Sanders WE, Brinkhous KM, Read MS. An animal model of thrombotic thrombocytopenia with von Willebrand factor deficiency: the role of botrocetin in studies of human TTP. In: Kaplan B, Trompeter R, Moake J, eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:499-512.
66. Sanders WE, Reddick RL, Nichols TC, Brinkhous KM, Read MS. Thrombotic thrombocytopenia induced in dogs and pigs: The role of plasma and platelet vWF in animal models of thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol. 1995;15(6):793-800.
67. Wagner DD, Ginsburg D. Structure, biology, and genetics of von Willebrand factor. In: Huffman R, et al, eds. Hematology: Basic Principles and Practice. New York: Churchill Livingstone; 1995:1717-25.
68. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307:1432-5.
69. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 1986;78:1456-61.
70. Moake JL, Turner NA, Stathopoulos NA, Nolasco L, Hellums JD. Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 1988;71:1366-74.
71. O'Brien JR, Etherington MD. The endothelial von Willebrand factor in venous occlusion blood. Thromb Haemost. 1997;78:1528-9.
72. Frangos JA, Moake JL, Nolasco L, Phillips MD, McIntire LV. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells. Am J Physiol. 1989;256:H1635-44.
73. Phillips MD, Moake JL, Nolasco L, Garcia R. Plasma von Willebrand factor processing activity functions like a disulfide bond reductase: reversible decrease of multimer size (abstract). Thromb Haemost. 1993;69:2342.
74. Tsai HM, Sussman I, Nagel RL. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 1994;83:2171-9.
75. Tsai HM. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its confirmation and requires calcium ion. Blood. 1996;87:4235-44.
76. Furlan M, Robles R, Lammle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87:4223-34.
77. Stathakis P, Fitzgerald M, Matthias LJ. Generation of angiostatin by reduction and proteolysis of plasmin: catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem. 1997;272:20641-5.
78. Moake JL, McPherson PD. Abnormalities of von Willebrand factoi multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Am J Med. 1989;87:3-9N.
79. Moake JL, McPherson PD. von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. Transfus Med. 1990;4:163-8.
80. Pereira A, Monteagudo J, Bono A, Lopez-Guillermo A, Ordinas A. Effect of splenectomy on von Willebrand factor multimeric structure in thrombotic thrombocytopenic purpura refractory to plasma exchange. Blood Coag Fibrinol. 1993;4:783-6.
81. Ruggenenti P, Galbusera M, Cornejo RP, Bellavita P, Remuzzi G. Thrombotic thrombocytopenia purpura: evidence that infusion rather than removal of plasma induces remission of disease. Am J Kidney Dis. 1993;21:314-8.
82. Tatewaki W. Multimeric composition of von Willebrand factor in thrombotic thrombocytopenia purpura. Nippon Rinsho-Japanese J Clin Med. 1993;51:146-50.
83. Chow TW, Turner NA, Chintagumpala M, Hellums JD, Moake JL. Direct quantification of increased von Willebrand factor binding to platelets in chronic thrombotic thrombocytopenic purpura (abstract). Blood. 1995;86:88.
84. Moake JL. Thrombotic thrombocytopenic purpura. Thromb Haemost. 1995;74:240-5.
85. Chow TW, Turner NA, McPherson P, Noalsco L, Chintagumpala M, Rice L, Moake JL. Platelet-bound von Willebrand factor (vWF) is consistently elevated during acute episodes of adult thrombotic thrombocytopenic purpura (TTP) (abstract). Blood. 1996;88:518.
86. Hoffman M, Monroe DM, Roberts HR. Platelet activation with thrombotic thrombocytopenic purpura. Am J Hematol. 1993;42:182-5.
87. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lammle B. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89:3097-103.
88. Tsai HM, Lian EC-Y. Inhibitors to vWf-cleaving metalloproteinase in thrombotic thrombocytopenic purpura (abstract). Blood. 1997;90(suppl1):2620.
89. Krause M, Furlan M, Ehrenforth S. Relevance of the von Willebrand factor cleaving protease in the diagnosis and clinical course in patients with thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) (abstract). Blood. 1997;90(suppl1):404.
90. Chow TW, Turner NA, Chintagumpala M, McPherson PD, Noalsco LH, Rice L, et al. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol. 1998;57:293-302.
91. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1985;65:1232-6.
92. Peterson DM, Stathopoulos NA, Giorgio TD, Hellums JD, Moake JL. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb/IIIa. Blood. 1987;69:625-8.
93. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 1992;80:113-20.
94. McCrary JK, Nolasco LJ, Hellums JD, Kroll MH, Turner NA, Moake JL. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress. Ann Biomed Eng. 1995;23:787-93.
95. Goto S, Salomon DR, Ikeda Y, Ruggeri ZM. Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets. J Biol Chem. 1995;270(40):23352-61.
96. Konstantopoulos K, Chow TW, Turner NA, Hellums JD, Moake JL. Shear stress induced binding of von Willebrand factor to platelets. Biorheology. 1997;34:57-72.
97. Karpman D, Lethagen S, Kristoffersson AC, Holmberg L. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura. Thromb Haemost. 1997;1997:1456-62.
98. Wick TM, Moake JL, Udden MM, McIntire LV. Unusually large von Willebrand factor multimers preferentially promote young sickle and non-sickle young erythrocyte adhesion to endothelial cells. Am J Hematol. 1993;42:284-92.
99. Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells. Blood. 1992;80:2634-42.
100. Shepard KV, Bukowski RM. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol. 1987;24:178-93.
101. Byrnes JJ. Plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Semin Thromb Hemost. 1981; 7:9-14.
102. Moake JL. TTP: desperation, empiricism, progress. N Engl J Med. 1991;325:426-8.
103. Byrnes JJ, Moake JL, Panpit K, Periman P. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura. Am J Hematol. 1990;34:169-74.
104. Rock G, Shumack KH, Button DM, Buskard NA, Nair RC. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol. 1996;94:383-6.
105. Moake JL, Rudy CK, Troll JH, Schafer AI. Weinstein MJ, Colannino NM, Hong SL. Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine. Am J Hematol. 1985;20:73-9.
106. Gordon LI, Kwaan HC, Rossi EC. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy. Semin Hematol. 1987;24:194-201.
107. Gutterman LA, Stevenson TD. Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA. 1982; 247:1433-6.
108. Rowe JM, Francis CW, Cyran EM, Marder VJ. Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers. Am J Hematol. 1985;20:161-8.
109. Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood. 1992;80:1890-5.
110. Rosove MH, Ho WG, Goldfinger D. Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura. Ann Intern Med. 1982;96:27-33.
111. del Zoppo GJ. Antiplatelet therapy in thrombotic thrombocytopenic purpura. Semin Hematol. 1987;24:130-139.
112. Phillips MD. Antiplatelet agents in thrombotic thrombocytopenic purpura. In: Kaplan B, Trompeter R, Moake J, eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:531-40.
113. Cachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, et al. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol. 1995; 91:434-44.
114. Cattaneo M, Lombardi R, Bettega D, Lecchi A, Mannucci PM. Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine. Arterioscler Thromb. 1993;13:393-7.
115. 2 and theophylline on the response of platelets subjected to shear stress. Blood. 1981;58:678-81.
116. Crowther MA, Heddle N, Hayward CPM, Warkentin T, Kelton JG. Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med. 1996;125:294-6.
117. Gaddis TG, Guthrie TH, Drew MJ. Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. Am J Hematol. 1997;55:55-8.
118. Sugimoto M, Ricca G, Hrinda ME, Schreiber AB, Searfoss GH, Bottini E, Ruggeri ZM. Functional modulation of the isolated glycoprotein Ib-binding domain on von Willebrand factor expressed in Escherichia coli. Biochemistry. 1991;30:5202-9.
119. Turner NA, Moake JL, Kama TS, McIntire LV. Comparative effects on platelet aggregation in real-time under flowing conditions of in vivo aspirin, heparin and monoclonal antibody 7E3 against glycoprotein IIb-IIIa. Circulation. 1995;91:1354-61.
120. Kamat SG, Turner NA, Konstantopoulos K, Hellums JD, McIntire LV, Kleiman NS, Moake JL. Effects of Integrelin on platelet function in flow models of arterial thrombosis. J Cardiovasc Pharmacol. 1997 (in press).
121. Moake JL. von Willebrand factor abnormalities in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. In: Kaplan B, Trompeter R, Moake J, eds. Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura. New York: Marcel Dekker; 1992:459-71.
122. Moake JL, Eisenstaedt RS. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. In: Coleman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practices. 3rd edition. Philadelphia: JB Lippincott; 1994:1064-75.
123. Moake JL. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage. Boston: Blackwell Scientific; 1994:517-28.